Related Experiment Video
Updated: May 26, 2025

Primary Culture of Mouse Dopaminergic Neurons
Published on: September 8, 2014
Synaptic Interactions Between Serotonergic and Dopaminergic Systems in Parkinson's Disease
Gioia Marino1,2, Federica Campanelli1, Giuseppina Natale1,3
1Section of Neurology, Department of Neuroscience, Università Cattolica del Sacro Cuore, Rome, 00168, Italy.
None:
Since both serotonergic and dopaminergic afferents densely innervate many parts of the central nervous system, intact crosstalk between serotonin (5-HT) and dopamine (DA) transmission is essential for regulating synaptic plasticity in the striatum (STR), prefrontal cortex (PFC), and hippocampus (HPC). Experimental models have provided strong evidence of a synergistic action of DA and 5-HT convergent release in PFC, HPC, and STR to modulate motor control, learning, and memory processes. In this review, we will discuss the mechanisms underlying the actions of agonists and antagonists of 5-HT and DA receptors on striatal synaptic plasticity in physiological conditions and Parkinson's disease (PD), a movement disorder in which an imbalance of these two neurotransmitter systems has been hypothesized. This review will also discuss the interactions between 5-HT and DA in PFC and HPC, with particular regard to the influence of this crosstalk on synaptic plasticity and learning. Finally, we will provide an overview of how stimulation or inhibition of DA and 5- HT receptors affects these neurotransmitter expression levels in the three brain regions of interest.
Related Concept Videos
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease: Overview
Drugs Affecting Neurotransmitter Synthesis
Neural Regulation
Excitatory and Inhibitory Effects of Neurotransmitters
Drugs Affecting Neurotransmitter Release or Uptake

